• Linoleic Acid Workflow and QC Guide

  2026-08-30

  This guide explains how to prepare and control Linoleic Acid (C18:2(9Z,12Z)) for oxidative stress, erythrocyte, epithelial migration, and nutritional deficiency workflows. It is suited to freshly prepared in vitro or animal-study dosing solutions, but not to aqueous protocols or experiments requiring long-term stock-solution stability.

• Pioglitazone Workflows for PPARγ Research

  2026-08-29

  Build reproducible Pioglitazone assays that connect PPARγ activation with macrophage polarization, metabolic regulation, and tissue-protective phenotypes. This practical guide combines formulation guidance, DSS-colitis workflow design, assay controls, and troubleshooting for translationally relevant bench studies.

• Mouse Neutrophil Cell Isolation Kit for Tumor Studies

  2026-08-28

  Build rapid, low-activation neutrophil workflows from mouse bone marrow, blood, or spleen for immunophenotyping and functional assays. Negative selection preserves an unlabeled target population, creating a practical starting point for testing neutrophil-directed mRNA nanovaccines and other tumor-immunity strategies.

• Why (S)-Mephenytoin Matters in Intestinal Organoids

  2026-08-28

  Human pluripotent stem cell-derived intestinal organoids are creating more physiologically relevant platforms for pharmacokinetic studies. This article explains how (S)-Mephenytoin, a mechanistically defined CYP2C19 substrate, can connect enzyme kinetics with organoid-based oxidative drug metabolism while highlighting the validation steps required for translational confidence.

• C34 TLR4 Inhibitor: From Target to Assay Logic

  2026-08-27

  C34 is a selective TLR4 inhibitor for dissecting LPS-driven inflammation in macrophages, enterocytes, and microglia. This article translates mechanistic evidence from Taxus chinensis research into practical assay decisions, controls, and interpretation strategies.

• Bafilomycin A1: From V-ATPase to Translation

  2026-08-27

  Bafilomycin A1 is more than a lysosomal research reagent: it is a precision probe for testing how proton gradients shape cell biology, viral entry, and translational phenotypes. This article interprets the grass carp reovirus inhibitor study, defines practical validation strategies, and shows where a selective, reversible V-ATPase inhibitor strengthens experimental decision-making.

• L1023 Anti-Cancer Compound Library Guide

  2026-08-26

  This scenario-based guide shows how SKU L1023 can improve compound handling, pathway coverage, and interpretation in cancer cell viability and cytotoxicity workflows. It connects practical screening decisions with product specifications and recent evidence on MCL1-driven tamoxifen resistance.

• Chemically Modified NGF mRNA for Peripheral Neuropathy

  2026-08-26

  The reference study engineered NGFR100W mRNA with a redesigned secretion signal, codon optimization, and N1-methylpseudouridine modification, then delivered it with lipid nanoparticles. In mouse and cell models, the approach supported neurite growth and recovery of intraepidermal nerve fibers while producing less nociceptive activity than wild-type NGF.

• TRPV1/TRPA1 Control of TSLP in Nasal Epithelium

  2026-08-25

  The reference study identifies a calcium-dependent NFAT pathway through which TRPV1 and TRPA1 activation stimulates TSLP production in nasal epithelial cells. Its combination of pharmacological inhibition, siRNA, calcium chelation, and NFAT localization provides a useful framework for interpreting epithelial ion-channel signaling in upper-airway inflammation.

• PMSF for Protein Extraction: Workflow & Troubleshooting

  2026-08-25

  PMSF provides focused serine protease protection for tissue and cell lysates, Western blots, and fragile multiprotein complexes. This guide connects its chemistry with practical sample-preparation decisions, including when a broad inhibitor strategy is preferable.

• Protease Inhibitor Cocktail for DFCP1–ATGL Assays

  2026-08-24

  Protect DFCP1–ATGL complexes and phosphorylation-sensitive readouts during starvation and lipid droplet extraction. This workflow shows when a water-soluble Protease Inhibitor Cocktail improves Western blotting, Co-IP, imaging, and proteomics—and when EDTA requires a separate validation step.

• Propranolol in Translational Assay Design

  2026-08-24

  Propranolol is more than a cardiovascular tool: it can help researchers interrogate how adrenergic signaling shapes complex tissue responses. This article connects β-adrenergic pharmacology with the multiplexed injury-and-regeneration assays described in an avian inner-ear protocol, while defining practical controls and interpretive limits.

• LDH Cytotoxicity Assay Kit: Practical Guide

  2026-08-23

  The LDH Cytotoxicity Assay Kit provides a non-radioactive approach to cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is suitable for endpoint cell damage quantification and viability studies, but it does not identify a specific cell-death mechanism or replace pathway-focused assays.

• MVC Activates RhoA/ROCK1 to Disrupt Tight Junctions

  2026-08-22

  The reference study identifies a direct interaction between MVC capsid protein VP2 and ROCK1 and connects this interaction to RhoA/ROCK1/MLC2-dependent tight-junction remodeling. Its findings position occludin exposure as a mechanistic step in viral entry and provide a framework for testing pathway-directed interventions without assuming that all RhoA-related inhibitors act through the same molecular target.

• High Viscosity, P-gp, and Chemoresistance

  2026-08-22

  The reference study identifies extracellular fluid viscosity as a mechanical regulator of doxorubicin resistance, linking cytoskeletal remodeling and water influx to TRPV4–YAP-dependent P-gp upregulation. Its findings suggest that viscosity-sensitive mechanotransduction and pharmacological transporter inhibition should be evaluated together in studies of tumor drug resistance.

7784 records 2/519 page Previous Next 12345 下5页 Last page